{
"id":"mk19_a_np_s5",
"subspecialtyId":"np",
"title":"Chronic Tubulointerstitial Nephritis",
"jsonContent":{
"type":"section",
"id":"mk19_a_np_s5",
"title":{
"__html":"Chronic Tubulointerstitial Nephritis"
},
"titleNode":{
"type":"section-title",
"hlId":"f6ec1a",
"children":[
"Chronic Tubulointerstitial Nephritis"
]
},
"children":[
{
"type":"section",
"id":"mk19_a_np_s5_1",
"title":{
"__html":"Epidemiology and Pathophysiology"
},
"titleNode":{
"type":"section-title",
"hlId":"c25aa6",
"children":[
"Epidemiology and Pathophysiology"
]
},
"children":[
{
"type":"p",
"hlId":"d8a8db",
"children":[
"Tubulointerstitial nephritis (TIN) is characterized by damage to the renal tubules and interstitium. TIN can be acute or chronic. Acute interstitial nephritis is commonly due to allergic drug reactions or infection and can cause acute kidney injury within days to weeks. It is characterized by inflammation and edema of the renal interstitium and tubules, which generally improves after the offending drug is discontinued or the underlying disease is treated (see ",
{
"type":"cross-reference",
"target":"mk19_a_np_s9_5_2_2",
"children":[
"Acute Kidney Injury"
]
},
"). Chronic TIN (CTIN) causes a slow decline in kidney function over months and years and is characterized by interstitial scarring, fibrosis, and tubular atrophy. Acute interstitial nephritis can progress to CTIN over time. CTIN can also develop in the setting of chronic primary glomerular disease, vascular diseases, and ischemia secondary to atherosclerosis and hypertension."
]
}
]
},
{
"type":"section",
"id":"mk19_a_np_s5_2",
"title":{
"__html":"Diagnosis and Evaluation"
},
"titleNode":{
"type":"section-title",
"hlId":"21d361",
"children":[
"Diagnosis and Evaluation"
]
},
"children":[
{
"type":"p",
"hlId":"50af3f",
"children":[
"CTIN is often asymptomatic until severe loss of kidney function occurs. Patients frequently present with only an elevated serum creatinine, although they may have symptoms such as polyuria and nocturia due to renal concentrating defects."
]
},
{
"type":"p",
"hlId":"587c18",
"children":[
"A careful history with a review of medications and symptoms suggesting nonpharmacologic triggers should be performed to determine the cause of CTIN ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_a_np_t19",
"wrapId":"1",
"children":[
"Table 19"
]
}
]
}
]
},
" and ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_a_np_t20",
"wrapId":"1",
"children":[
"Table 20"
]
}
]
},
")"
]
},
". A thorough physical examination infrequently provides clues to the diagnosis. Patients may be hypertensive. Urinalysis may be normal or demonstrate pyuria and/or proteinuria <1500 mg/24 h. Nonalbumin proteinuria will require a random (spot) total protein-creatinine ratio determination. See ",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_a_np_t21",
"wrapId":"1",
"children":[
"Table 21"
]
}
]
},
" for other laboratory manifestations of CTIN. Kidney ultrasound typically reveals small kidneys if disease is advanced. Kidney biopsy may establish a definitive diagnosis."
]
},
{
"type":"inline-wrap",
"wrapId":"1",
"contentIds":[
"mk19_a_np_t19",
"mk19_a_np_t20",
"mk19_a_np_t21"
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"96100a",
"children":[
"Chronic tubulointerstitial nephritis is characterized by interstitial scarring, fibrosis, and tubular atrophy and results in a slow decline in kidney function over months and years."
]
},
{
"type":"keypoint",
"hlId":"888f8d",
"children":[
"Features of chronic tubulointerstitial nephritis include polyuria and nocturia due to renal concentrating defects; hypertension; and a urinalysis that is normal or demonstrates pyuria and/or proteinuria <1500 mg/24 h."
]
},
{
"type":"keypoint",
"hlId":"542e55",
"children":[
"Some clinical features of chronic tubulointerstitial nephritis may reflect tubular dysfunction, including glucosuria and other features of Fanconi syndrome, normal anion gap metabolic acidosis, hypokalemia, or hyperkalemia."
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_a_np_s5_3",
"title":{
"__html":"Causes"
},
"titleNode":{
"type":"section-title",
"hlId":"82887a",
"children":[
"Causes"
]
},
"children":[
{
"type":"p",
"hlId":"8cf6ed",
"children":[
"See ",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_a_np_t19",
"wrapId":"2",
"children":[
"Table 19"
]
}
]
},
" and ",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_a_np_t20",
"wrapId":"2",
"children":[
"Table 20"
]
}
]
},
" for the pharmacologic and nonpharmacologic causes of TIN."
]
},
{
"type":"inline-wrap",
"wrapId":"2",
"contentIds":[
"mk19_a_np_t19",
"mk19_a_np_t20"
]
},
{
"type":"section",
"id":"mk19_a_np_s5_3_1",
"title":{
"__html":"Immunologic Diseases"
},
"titleNode":{
"type":"section-title",
"hlId":"fc8dcf",
"children":[
"Immunologic Diseases"
]
},
"children":[
{
"type":"section",
"id":"mk19_a_np_s5_3_1_1",
"title":{
"__html":"Sjögren Syndrome"
},
"titleNode":{
"type":"section-title",
"hlId":"dd4b0f",
"children":[
"Sjögren Syndrome"
]
},
"children":[
{
"type":"p",
"hlId":"03560e",
"children":[
"Kidney involvement in Sjögren syndrome may include interstitial nephritis, distal (type 1) renal tubular acidosis (RTA), and glomerulonephritis. Nephrolithiasis, nephrocalcinosis, and progressive kidney disease may also occur."
]
}
]
},
{
"type":"section",
"id":"mk19_a_np_s5_3_1_2",
"title":{
"__html":"Sarcoidosis"
},
"titleNode":{
"type":"section-title",
"hlId":"c57e04",
"children":[
"Sarcoidosis"
]
},
"children":[
{
"type":"p",
"hlId":"f53fc1",
"children":[
"Kidney involvement in sarcoidosis is not uncommon and can manifest as nephrocalcinosis from hypercalcemia and hypercalciuria, obstructive uropathy, and TIN with granuloma formation. Kidney recovery is often incomplete."
]
}
]
},
{
"type":"section",
"id":"mk19_a_np_s5_3_1_3",
"title":{
"__html":"Systemic Lupus Erythematosus"
},
"titleNode":{
"type":"section-title",
"hlId":"41337c",
"children":[
"Systemic Lupus Erythematosus"
]
},
"children":[
{
"type":"p",
"hlId":"541a9e",
"children":[
"TIN may occur in systemic lupus erythematosus and is often associated with concurrent glomerular disease, but can also be the only manifestation of lupus nephritis. The severity of TIN is a useful predictor of progressive kidney disease."
]
}
]
},
{
"type":"section",
"id":"mk19_a_np_s5_3_1_4",
"title":{
"__html":"IgG4-Related Disease"
},
"titleNode":{
"type":"section-title",
"hlId":"9e59f1",
"children":[
"IgG4-Related Disease"
]
},
"children":[
{
"type":"p",
"hlId":"5f9252",
"children":[
"TIN is the most common renal manifestation of systemic IgG4-related disease and is characterized by abundant IgG4-positive plasma cell interstitial infiltrates. Other features may include hypocomplementemia, peripheral eosinophilia, and renal masses. See ",
{
"type":"cross-reference",
"target":"mk19_b_rm_s15_6",
"children":[
"MKSAP 19 Rheumatology"
]
},
" for more information."
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_a_np_s5_3_2",
"title":{
"__html":"Infections"
},
"titleNode":{
"type":"section-title",
"hlId":"2c194f",
"children":[
"Infections"
]
},
"children":[
{
"type":"p",
"hlId":"7e3b3e",
"children":[
"Certain infections are associated with acute interstitial nephritis and can contribute to CTIN. Etiologies include bacterial (such as brucellosis and tuberculosis), viral, fungal, and parasitic infections."
]
},
{
"type":"p",
"hlId":"e4313e",
"children":[
"In immunosuppressed patients with kidney transplants, BK polyoma virus causes an interstitial nephritis that is difficult to distinguish by biopsy from acute cellular rejection. Urine and serum BK polyoma virus polymerase chain reaction titers and a specific BK stain (SV40) help determine etiology. The most effective intervention is reduction of immunosuppressive therapy."
]
},
{
"type":"p",
"hlId":"0d5eea",
"children":[
"Chronic pyelonephritis resulting from chronic infections or vesicoureteral reflux may cause CTIN. Patients may present with fever, chills, dysuria, flank or back pain, and hypertension. Persistent chronic pyelonephritis can progress to localized xanthogranulomatous pyelonephritis, which is characterized by a destructive mass that invades the renal parenchyma."
]
}
]
},
{
"type":"section",
"id":"mk19_a_np_s5_3_3",
"title":{
"__html":"Malignancy"
},
"titleNode":{
"type":"section-title",
"hlId":"986a4f",
"children":[
"Malignancy"
]
},
"children":[
{
"type":"p",
"hlId":"75ee08",
"children":[
"Lymphoma and acute leukemia can infiltrate the kidney, causing TIN. Presenting features include proteinuria, sterile pyuria, and enlarged kidneys. Plasma cell dyscrasias such as multiple myeloma can cause TIN in the form of myeloma cast nephropathy, Fanconi syndrome, or interstitial light chain deposition."
]
}
]
},
{
"type":"section",
"id":"mk19_a_np_s5_3_4",
"title":{
"__html":"Medications"
},
"titleNode":{
"type":"section-title",
"hlId":"ba25cf",
"children":[
"Medications"
]
},
"children":[
{
"type":"p",
"hlId":"47354c",
"children":[
"Medication-induced acute interstitial nephritis ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_a_np_t19",
"wrapId":"3",
"children":[
"Table 19"
]
}
]
},
")"
]
},
" may evolve to CTIN due to protracted exposure to an offending agent. The most common associated drug classes include antibiotics, NSAIDs, and proton pump inhibitors."
]
},
{
"type":"inline-wrap",
"wrapId":"3",
"contentIds":[
"mk19_a_np_t19"
]
},
{
"type":"section",
"id":"mk19_a_np_s5_3_4_1",
"title":{
"__html":"Analgesics"
},
"titleNode":{
"type":"section-title",
"hlId":"ec825e",
"children":[
"Analgesics"
]
},
"children":[
{
"type":"p",
"hlId":"9fa6ca",
"children":[
"Analgesic nephropathy was first described in patients taking combinations of phenacetin (banned since 1983) with aspirin, caffeine, acetaminophen, or NSAIDs. It can also occur with the individual drugs. When severe, analgesic nephropathy is associated with renal papillary necrosis, manifesting as gross hematuria, flank pain, and, occasionally, obstruction and infection. Affected individuals typically have a history of heavy analgesic use."
]
}
]
},
{
"type":"section",
"id":"mk19_a_np_s5_3_4_2",
"title":{
"__html":"Calcineurin Inhibitors"
},
"titleNode":{
"type":"section-title",
"hlId":"9e1b04",
"children":[
"Calcineurin Inhibitors"
]
},
"children":[
{
"type":"p",
"hlId":"25b815",
"children":[
"The calcineurin inhibitors cyclosporine and tacrolimus can cause CTIN. Longer durations of exposure increase risk for CTIN. Associated thrombotic microangiopathy is uncommon but may contribute to acute or chronic kidney injury."
]
}
]
},
{
"type":"section",
"id":"mk19_a_np_s5_3_4_3",
"title":{
"__html":"Lithium"
},
"titleNode":{
"type":"section-title",
"hlId":"a0a569",
"children":[
"Lithium"
]
},
"children":[
{
"type":"p",
"hlId":"69a31c",
"children":[
"Lithium exposure can cause distal tubular dysfunction (type 1 hypokalemic distal RTA), nephrogenic diabetes insipidus, and CTIN. CTIN occurs in up to 15% to 20% of long-term lithium users. Risk factors for CTIN include advanced age, cumulative dose, and repeated episodes of lithium toxicity with high serum levels. Kidney dysfunction can progress to end-stage kidney disease even after discontinuation of lithium."
]
}
]
},
{
"type":"section",
"id":"mk19_a_np_s5_3_4_4",
"title":{
"__html":"Antineoplastic Agents"
},
"titleNode":{
"type":"section-title",
"hlId":"0004b8",
"children":[
"Antineoplastic Agents"
]
},
"children":[
{
"type":"p",
"hlId":"476029",
"children":[
"Multiple chemotherapy agents can cause TIN. Immune checkpoint inhibitors and tyrosine kinase inhibitors are the main classes implicated. Other associated agents with TIN include ifosfamide, pemetrexed, lenalidomide, vemurafenib, and nitrosoureas (particularly streptozotocin and semustine)."
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_a_np_s5_3_5",
"title":{
"__html":"Drugs of Abuse"
},
"titleNode":{
"type":"section-title",
"hlId":"55e051",
"children":[
"Drugs of Abuse"
]
},
"children":[
{
"type":"p",
"hlId":"44fe5b",
"children":[
"Drugs of abuse such as synthetic cannabinoids, anabolic androgenic steroids, toluene, and cocaine are associated with acute interstitial nephritis. The incidence of CTIN associated with repeated exposure is unknown."
]
}
]
},
{
"type":"section",
"id":"mk19_a_np_s5_3_6",
"title":{
"__html":"Lead"
},
"titleNode":{
"type":"section-title",
"hlId":"a745d9",
"children":[
"Lead"
]
},
"children":[
{
"type":"p",
"hlId":"19284b",
"children":[
"Lead can result in tubular dysfunction and CTIN. Occupational exposure to lead occurs from welding, smelting, the battery industry, and mining. Toxicity may also develop after months to years of exposure to lead in water, soil, paint, or food products. Gout is common. The clinical diagnosis of lead nephropathy is based on history of exposure, evidence of kidney dysfunction, and blood lead levels. Levels may be normal if lead exposure has abated."
]
}
]
},
{
"type":"section",
"id":"mk19_a_np_s5_3_7",
"title":{
"__html":"Chronic Interstitial Nephritis in Agricultural Communities"
},
"titleNode":{
"type":"section-title",
"hlId":"be672e",
"children":[
"Chronic Interstitial Nephritis in Agricultural Communities"
]
},
"children":[
{
"type":"p",
"hlId":"77d108",
"children":[
"Chronic interstitial nephritis in agricultural communities (CINAC) is an emerging public health problem in many Central American and Asian countries. CINAC is observed most commonly in young- to middle-age male agricultural workers and often progresses to end-stage kidney disease. The precise etiology is uncertain, but it is postulated that there is an association with frequent dehydration, pesticide exposure, and other environmental contaminants."
]
}
]
},
{
"type":"section",
"id":"mk19_a_np_s5_3_8",
"title":{
"__html":"Aristolochic Acid Nephropathy"
},
"titleNode":{
"type":"section-title",
"hlId":"a28d45",
"children":[
"Aristolochic Acid Nephropathy"
]
},
"children":[
{
"type":"p",
"hlId":"2bf2f3",
"children":[
"Aristolochic acid nephropathy (Balkan nephropathy) is a cause of CTIN first described in Southeast Europe and later identified in consumers of certain Chinese herbs. It is caused by ingestion of a toxin from the ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Aristolochia clematitis"
]
},
" plant",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"."
]
},
" Aristolochic acid nephropathy is associated with progression to end-stage kidney disease as well as urothelial cancers. Cystoscopy with retrograde pyelography should be performed in patients with aristolochic acid nephropathy and nonglomerular hematuria."
]
}
]
},
{
"type":"section",
"id":"mk19_a_np_s5_3_9",
"title":{
"__html":"Obstruction"
},
"titleNode":{
"type":"section-title",
"hlId":"81cd6d",
"children":[
"Obstruction"
]
},
"children":[
{
"type":"p",
"hlId":"7587e5",
"children":[
"Obstructive uropathy from prostate disease, malignancy, nephrolithiasis, pelvic radiation, medications such as methysergide, and retroperitoneal fibrosis can cause CTIN and progressive kidney dysfunction. RTA, hyperkalemia, and mild proteinuria are common."
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"bcb317",
"children":[
"Causes of chronic tubulointerstitial nephritis include various immunologic diseases, infections, malignancy, medications, drugs of abuse, lead, and obstructive uropathy."
]
},
{
"type":"keypoint",
"hlId":"937b37",
"children":[
"More recently recognized risk factors for chronic tubulointerstitial nephritis include chronic interstitial nephritis in agricultural communities, affecting young- to middle-age male agricultural workers, as well as aristolochic acid nephropathy from the ingestion of a Chinese herb toxin."
]
}
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_a_np_s5_4",
"title":{
"__html":"Management"
},
"titleNode":{
"type":"section-title",
"hlId":"fe4dbc",
"children":[
"Management"
]
},
"children":[
{
"type":"p",
"hlId":"671158",
"children":[
"Management of acute and chronic TIN involves treating the underlying cause by discontinuing medications, drugs of abuse, or toxin exposure; administering immunosuppressive therapy (often glucocorticoids) for immunologic or drug-related allergic causes; treating infection or malignancy; and relieving obstruction. Treatment of lead nephropathy consists of ethylenediaminetetraacetic acid chelation therapy or oral succimer. In patients with CTIN and progressive kidney disease, management includes control of blood pressure and treatment of proteinuria and metabolic abnormalities (see ",
{
"type":"cross-reference",
"target":"mk19_a_np_s12_6",
"children":[
"Chronic Kidney Disease"
]
},
")."
]
}
]
},
{
"type":"section",
"id":"mk19_a_np_s5_5",
"bibliography":true,
"title":{
"__html":"Bibliography"
},
"titleNode":{
"type":"section-title",
"hlId":"a7cc81",
"children":[
"Bibliography"
]
},
"children":[
{
"type":"references",
"children":[
{
"type":"reference",
"children":[
"François H, Mariette X. Renal involvement in primary Sjögren syndrome. Nat Rev Nephrol. 2016;12:82-93. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/26568188",
"target":"_blank"
},
"children":[
"PMID: 26568188"
]
},
" doi:10.1038/nrneph.2015.174"
]
},
{
"type":"reference",
"children":[
"Jelakovic B, Dika Z, Arlt VM, et al. Balkan endemic nephropathy and the causative role of aristolochic acid. Semin Nephrol. 2019;39:284-96. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/31054628",
"target":"_blank"
},
"children":[
"PMID: 31054628"
]
},
" doi:10.1016/j.semnephrol.2019.02.007"
]
},
{
"type":"reference",
"children":[
"Lazarus B, Chen Y, Wilson FP, et al. Proton pump inhibitor use and the risk of chronic kidney disease. JAMA Intern Med. 2016;176:238-46. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/26752337",
"target":"_blank"
},
"children":[
"PMID: 26752337"
]
},
" doi:10.1001/jamainternmed.2015.7193"
]
},
{
"type":"reference",
"children":[
"Nast CC. Medication-induced interstitial nephritis in the 21st century. Adv Chronic Kidney Dis. 2017;24:72-9. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/28284382",
"target":"_blank"
},
"children":[
"PMID: 28284382"
]
},
" doi:10.1053/j.ackd.2016.11.016"
]
},
{
"type":"reference",
"children":[
"Orantes-Navarro CM, Herrera-Valdés R, Almaguer-López M, et al. Toward a comprehensive hypothesis of chronic interstitial nephritis in agricultural communities. Adv Chronic Kidney Dis. 2017;24:101-6. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/28284375",
"target":"_blank"
},
"children":[
"PMID: 28284375"
]
},
" doi:10.1053/j.ackd.2017.01.001"
]
},
{
"type":"reference",
"children":[
"Perazella MA. Clinical approach to diagnosing acute and chronic tubulointerstitial disease. Adv Chronic Kidney Dis. 2017;24:57-63. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/28284380",
"target":"_blank"
},
"children":[
"PMID: 28284380"
]
},
" doi:10.1053/j.ackd.2016.08.003"
]
},
{
"type":"reference",
"children":[
"Shah S, Carter-Monroe N, Atta MG. Granulomatous interstitial nephritis. Clin Kidney J. 2015;8:516-23. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/26413275",
"target":"_blank"
},
"children":[
"PMID: 26413275"
]
},
" doi:10.1093/ckj/sfv053"
]
},
{
"type":"reference",
"children":[
"Zhang P, Cornell LD. IgG4-related tubulointerstitial nephritis. Adv Chronic Kidney Dis. 2017;24:94-100. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/28284385",
"target":"_blank"
},
"children":[
"PMID: 28284385"
]
},
" doi:10.1053/j.ackd.2016.12.001"
]
}
]
}
]
}
]
},
"tablesContent":{
"mk19_a_np_t19":{
"id":"mk19_a_np_t19",
"number":19,
"bookId":"np",
"title":{
"__html":"Pharmacologic Causes of Tubulointerstitial Nephritis"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"21d662",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 19. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_a_np_t19"
}
]
},
"Pharmacologic Causes of Tubulointerstitial Nephritis"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ec825e",
"class":"col hd l",
"children":[
"Analgesics"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"5306d1",
"class":"cell txt l",
"children":[
"Analgesic nephropathy (e.g., aspirin, caffeine, acetaminophen, NSAIDs [including COX-2 inhibitors]), or NSAID combinations)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"445236",
"class":"col hd l",
"children":[
"Antibiotics"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"16f01b",
"class":"cell txt l",
"children":[
"Penicillins (e.g., amoxicillin, methicillin, oxacillin)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e54947",
"class":"cell txt l",
"children":[
"Cephalosporins (e.g., cefazolin, cephalexin, cefoxitin)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"52838f",
"class":"cell txt l",
"children":[
"Fluoroquinolones (e.g., ciprofloxacin, levofloxacin)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ac2f3e",
"class":"cell txt l",
"children":[
"Sulfonamides (e.g., trimethoprim-sulfamethoxazole)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e87224",
"class":"cell txt l",
"children":[
"Macrolides (e.g., azithromycin, clarithromycin)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-6 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"335c29",
"class":"cell txt l",
"children":[
"Rifampin"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"9e1b04",
"class":"col hd l",
"children":[
"Calcineurin Inhibitors"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_3-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d5ad08",
"class":"cell txt l",
"children":[
"Cyclosporine"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_3-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"273268",
"class":"cell txt l",
"children":[
"Tacrolimus"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c83c2d",
"class":"col hd l",
"children":[
"Antineoplastics"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_4-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"3b4697",
"class":"cell txt l",
"children":[
"Immune checkpoint inhibitors (e.g., atezolizumab, ipilimumab)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_4-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"21f879",
"class":"cell txt l",
"children":[
"Tyrosine kinase inhibitors (e.g., sorafenib, sunitinib)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_4-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"991b8d",
"class":"cell txt l",
"children":[
"Ifosfamide"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_4-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"24372f",
"class":"cell txt l",
"children":[
"Pemetrexed"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_4-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"06d05b",
"class":"cell txt l",
"children":[
"Lenalidomide"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_4-6 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d7d028",
"class":"cell txt l",
"children":[
"Vemurafenib"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_4-7 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a1f202",
"class":"cell txt l",
"children":[
"Nitrosoureas (e.g., streptozotocin, semustine)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"3f69f4",
"class":"col hd l",
"children":[
"Gastrointestinal Therapeutics"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_5-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"32f956",
"class":"cell txt l",
"children":[
"Proton pump inhibitors (e.g., omeprazole, pantoprazole)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_5-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"2dc53f",
"class":"cell txt l",
"children":[
"H",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"2"
]
},
" blockers (e.g., ranitidine)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_5-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"bca769",
"class":"cell txt l",
"children":[
"5-Aminosalicylates (e.g., mesalazine, sulfasalazine)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_5-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"898acc",
"class":"cell txt l",
"children":[
"Sodium phosphate (can cause phosphate nephropathy)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"55e051",
"class":"col hd l",
"children":[
"Drugs of Abuse"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_6-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"056a9e",
"class":"cell txt l",
"children":[
"Synthetic cannabinoids"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_6-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"69cfdf",
"class":"cell txt l",
"children":[
"Anabolic androgenic steroids"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_6-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e65b4f",
"class":"cell txt l",
"children":[
"Toluene"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_6-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"0a1541",
"class":"cell txt l",
"children":[
"Cocaine"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"6311ae",
"class":"col hd l",
"children":[
"Other"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_7-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"8bc43c",
"class":"cell txt l",
"children":[
"Antiretrovirals (e.g., abacavir, indinavir, tenofovir)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_7-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"2e4c04",
"class":"cell txt l",
"children":[
"Allopurinol"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_7-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"53e502",
"class":"cell txt l",
"children":[
"Diuretics (e.g., thiazide, loop, potassium sparing)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_7-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a0a569",
"class":"cell txt l",
"children":[
"Lithium"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_7-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"bc9ce0",
"class":"cell txt l",
"children":[
"Antiepileptic drugs (e.g., carbamazepine, phenytoin, phenobarbital)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_7-6 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"45c30d",
"class":"cell txt l",
"children":[
"Antihypertensives (e.g., ACE inhibitors, angiotensin receptor blockers, calcium channel blockers)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_7-7 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"64626b",
"class":"cell txt l",
"children":[
"Prolonged exposure to any medication that can cause acute interstitial nephritis"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[

]
},
"mk19_a_np_t20":{
"id":"mk19_a_np_t20",
"number":20,
"bookId":"np",
"title":{
"__html":"Nonpharmacologic Causes of Chronic Tubulointerstitial Nephritis"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"c2f6a1",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 20. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_a_np_t20"
}
]
},
"Nonpharmacologic Causes of Chronic Tubulointerstitial Nephritis"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"fc8dcf",
"class":"col hd l",
"children":[
"Immunologic Diseases"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c57e04",
"class":"cell txt l",
"children":[
"Sarcoidosis"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ecc1e2",
"class":"cell txt l",
"children":[
"Sjögren syndrome"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"32ee95",
"class":"cell txt l",
"children":[
"Systemic lupus erythematosus"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d700eb",
"class":"cell txt l",
"children":[
"IgG4-related disease"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"9e8561",
"class":"cell txt l",
"children":[
"Tubulointerstitial nephritis with uveitis (TINU)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-6 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"aa90fa",
"class":"cell txt l",
"children":[
"Vasculitis"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"742696",
"class":"col hd l",
"children":[
"Toxic Causes"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"826b24",
"class":"cell txt l",
"children":[
"Aristolochic acid (Balkan) nephropathy (urologic evaluation is indicated due to increased risk for transitional cell [urothelial] carcinoma)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b411ae",
"class":"cell txt l",
"children":[
"Heavy metal nephropathy (e.g., lead, cadmium, mercury, arsenic, bismuth, chromium, copper, gold, iron, uranium)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a05a27",
"class":"cell txt l",
"children":[
"Chronic interstitial nephritis in agricultural communities"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"87f367",
"class":"col hd l",
"children":[
"Hereditary Tubulointerstitial Nephritis"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_3-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c20b83",
"class":"cell txt l",
"children":[
"Medullary cystic kidney disease"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_3-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"081a36",
"class":"cell txt l",
"children":[
"Mitochondrial disorders"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_3-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f1a344",
"class":"cell txt l",
"children":[
"Nephronophthisis"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"659055",
"class":"col hd l",
"children":[
"Infection-Related Causes"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_4-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"8af1d8",
"class":"cell txt l",
"children":[
"Viruses (notably, BK polyoma virus after kidney transplantation, HIV)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_4-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"17cf1d",
"class":"cell txt l",
"children":[
"Fungal infections"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_4-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"36e290",
"class":"cell txt l",
"children":[
"Parasitic infections"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_4-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c50523",
"class":"cell txt l",
"children":[
"Spirochetes"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_4-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d6a318",
"class":"cell txt l",
"children":[
"Chronic pyelonephritis"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_4-6 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"3904c9",
"class":"cell txt l",
"children":[
"Bacterial infections (e.g., brucellosis, tuberculosis)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"8c8607",
"class":"col hd l",
"children":[
"Malignancy-Related Causes"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_5-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"78bcaa",
"class":"cell txt l",
"children":[
"Leukemia"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_5-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"5feaae",
"class":"cell txt l",
"children":[
"Lymphoma"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_5-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"301d91",
"class":"cell txt l",
"children":[
"Malignancy-associated monoclonal gammopathies (e.g., multiple myeloma, plasmacytoma)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f8a519",
"class":"col hd l",
"children":[
"Metabolic Disorders"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_6-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"1764cf",
"class":"cell txt l",
"children":[
"Oxalate nephropathy"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_6-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e817e0",
"class":"cell txt l",
"children":[
"Uric acid nephropathy"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_6-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"689cd5",
"class":"cell txt l",
"children":[
"Nephrocalcinosis"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_6-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"245dc5",
"class":"cell txt l",
"children":[
"Hypokalemic nephropathy"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"1676f3",
"class":"col hd l",
"children":[
"Urinary Tract Obstruction"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_7-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"9499cc",
"class":"cell txt l",
"children":[
"Obstructive uropathy"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_7-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"3ed830",
"class":"cell txt l",
"children":[
"Nephrolithiasis"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_7-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"05bbe3",
"class":"cell txt l",
"children":[
"Reflux disease"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[

]
},
"mk19_a_np_t21":{
"id":"mk19_a_np_t21",
"number":21,
"bookId":"np",
"title":{
"__html":"Laboratory Manifestations of Chronic Tubulointerstitial Nephritis"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"b90ba4",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 21. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_a_np_t21"
}
]
},
"Laboratory Manifestations of Chronic Tubulointerstitial Nephritis"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"6c5c55",
"class":"col hd l",
"children":[
"Abnormality",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
}
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"82887a",
"class":"col hd l",
"children":[
"Causes"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ae12e1",
"class":"cell txt l",
"children":[
"Decline in GFR"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"6b3f86",
"class":"cell txt l",
"children":[
"Obstruction of tubules; damage to microvasculature; interstitial fibrosis and sclerosis of glomeruli"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"5fd998",
"class":"cell txt l",
"children":[
"Proximal tubular damage (Fanconi syndrome)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e3739c",
"class":"cell txt l",
"children":[
"Incomplete absorption and kidney wasting of glucose, phosphate, uric acid, bicarbonate, and amino acids"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"2f2e60",
"class":"cell txt l",
"children":[
"Normal anion gap metabolic acidosis"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ae1859",
"class":"cell txt l",
"children":[
"Proximal and distal RTA; decreased ammonia production"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"5df142",
"class":"cell txt l",
"children":[
"Polyuria and isosthenuria"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ca17fd",
"class":"cell txt l",
"children":[
"Decreased concentrating and diluting ability"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"40421f",
"class":"cell txt l",
"children":[
"Proteinuria"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f81786",
"class":"cell txt l",
"children":[
"Decreased tubular protein reabsorption (usually <1500 mg/24 h)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-6 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"754f8e",
"class":"cell txt l",
"children":[
"Hyperkalemia"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"1fac9d",
"class":"cell txt l",
"children":[
"Defect in potassium secretion (type 4 [hyperkalemic] distal RTA)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-7 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e32a97",
"class":"cell txt l",
"children":[
"Hypokalemia"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d1b6a7",
"class":"cell txt l",
"children":[
"Defect in potassium reabsorption (type 1 [hypokalemic] distal RTA)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-8 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"fc45c6",
"class":"cell txt l",
"children":[
"Anemia"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f6f225",
"class":"cell txt l",
"children":[
"Injury to erythropoietin-producing cells in the kidney"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[
[
"GFR = glomerular filtration rate; RTA = renal tubular acidosis."
],
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
},
"The degree of these abnormalities depends on the extent and location of injury."
]
]
}
}
}